1-1 of 1
Hui Tang, BS, MA, PhD
Close
Sort by
Journal Articles

A Phase II Study of Temsirolimus (CCI-779) in Combination with Rituximab in Patients with Relapsed or Refractory Mantle Cell Lymphoma.

Stephen M Ansell, Hui Tang, BS, MA, PhD, Paul Kurtin, Patricia Koenig, David J Inwards, Keith Shah, Thomas E Witzig, MD
Journal: Blood
Blood (2009) 114 (22): 1665.
https://doi.org/10.1182/blood.V114.22.1665.1665
Published: 2009